文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气创伤与烧伤

早期或晚期细菌性肺部感染增加雄性小鼠创伤性脑损伤后死亡率并长期损害单核细胞固有免疫功能

Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论小鼠创伤性脑损伤后3天或60天感染肺炎链球菌均增加死亡率(3天25% vs 0%,60天60% vs 5%),并长期损害单核细胞功能,提示伤后晚期呼吸道感染威胁可能被低估。

该实验研究采用成年雄性C57BL/6J小鼠,行假手术或中度控制性皮质撞击后,在伤后3天或60天经鼻感染肺炎链球菌(1500个菌落形成单位)或赋形剂。伤后3天感染TBI小鼠死亡率为25%,而感染假手术小鼠无死亡;伤后60天感染TBI小鼠死亡率为60%,感染假手术小鼠为5%。两组时间点TBI+Sp小鼠运动功能恢复均较差,皮质促炎标志物表达增加,肺单核细胞功能在伤后急性期受抑制、延迟感染时反而升高,肺细菌负荷和病理加重。作者认为TBI导致的单核细胞功能损害可能影响宿主对呼吸道感染的易感性,即使伤后晚期感染也可能比目前认识的更严重。

要点

  • 雄性小鼠TBI后3天感染肺炎链球菌死亡率为25%,假手术感染小鼠无死亡。
  • 雄性小鼠TBI后60天感染肺炎链球菌死亡率为60%,假手术感染小鼠为5%。
  • 早期和晚期感染后TBI+Sp小鼠运动功能恢复均差于TBI+PBS小鼠,皮质促炎标志物表达增加。
  • TBI后急性期肺单核细胞免疫抑制,不能产生白细胞介素-1β、肿瘤坏死因子-α或活性氧。
  • 延迟感染时TBI+Sp小鼠肺单核细胞白细胞介素-1β、肿瘤坏死因子-α和活性氧水平高于Sham+Sp小鼠,肺细菌负荷和病理增加。

适用人群与场景

  • 成年雄性C57BL/6J小鼠,行假手术或中度控制性皮质撞击后,在伤后3天或60天经鼻感染肺炎链球菌(1500个菌落形成单位)或赋形剂(磷酸盐缓冲液)。

研究设计与关键结果

  • 实验研究:成年雄性C57BL/6J小鼠行假手术或中度控制性皮质撞击,伤后3天或60天经鼻感染肺炎链球菌(1500个菌落形成单位)或磷酸盐缓冲液。
  • 伤后3天感染:TBI+Sp小鼠死亡率为25%,Sham+Sp小鼠无死亡。
  • 伤后60天感染:TBI+Sp小鼠死亡率为60%,Sham+Sp小鼠死亡率为5%。
  • 两个时间点TBI+Sp小鼠运动功能恢复均差于TBI+PBS小鼠,皮质促炎标志物表达高于TBI+PBS小鼠。
  • TBI后急性期TBI+Sp小鼠肺单核细胞免疫抑制,不能产生白细胞介素-1β、肿瘤坏死因子-α或活性氧;延迟感染时TBI+Sp小鼠肺单核细胞白细胞介素-1β、肿瘤坏死因子-α和活性氧水平高于Sham+Sp小鼠。
  • TBI+Sp小鼠肺细菌负荷和病理增加。

证据类型、等级与局限

  • 证据类型:实验研究(小鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,创伤性脑损伤导致单核细胞功能损害,可能影响宿主对呼吸道感染的易感性。
  • 作者认为,即使创伤性脑损伤后晚期发生呼吸道感染,也可能比目前认识的更严重。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Respiratory infections in the postacute phase of traumatic brain injury impede optimal recovery and contribute substantially to overall morbidity and mortality. This study investigated bidirectional innate immune responses between the injured brain and lung, using a controlled cortical impact model followed by secondary Streptococcus pneumoniae infection in mice.

DESIGN: Experimental study.

SETTING: Research laboratory.

SUBJECTS: Adult male C57BL/6J mice.

INTERVENTIONS: C57BL/6J mice were subjected to sham surgery or moderate-level controlled cortical impact and infected intranasally with S. pneumoniae (1,500 colony-forming units) or vehicle (phosphate-buffered saline) at 3 or 60 days post-injury.

MAIN RESULTS: At 3 days post-injury, S. pneumoniae-infected traumatic brain injury mice (TBI + Sp) had a 25% mortality rate, in contrast to no mortality in S. pneumoniae-infected sham (Sham + Sp) animals. TBI + Sp mice infected 60 days post-injury had a 60% mortality compared with 5% mortality in Sham + Sp mice. In both studies, TBI + Sp mice had poorer motor function recovery compared with TBI + PBS mice. There was increased expression of pro-inflammatory markers in cortex of TBI + Sp compared with TBI + PBS mice after both early and late infection, indicating enhanced post-traumatic neuroinflammation. In addition, monocytes from lungs of TBI + Sp mice were immunosuppressed acutely after traumatic brain injury and could not produce interleukin-1β, tumor necrosis factor-α, or reactive oxygen species. In contrast, after delayed infection monocytes from TBI + Sp mice had higher levels of interleukin-1β, tumor necrosis factor-α, and reactive oxygen species when compared with Sham + Sp mice. Increased bacterial burden and pathology was also found in lungs of TBI + Sp mice.

CONCLUSIONS: Traumatic brain injury causes monocyte functional impairments that may affect the host's susceptibility to respiratory infections. Chronically injured mice had greater mortality following S. pneumoniae infection, which suggests that respiratory infections even late after traumatic brain injury may pose a more serious threat than is currently appreciated.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Doran SJ, Henry RJ, Shirey KA, et al. Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function. Crit Care Med. 2020. PMID: 32149839. doi:10.1097/CCM.0000000000004273

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。